51. Mucoadhesive emulgel systems containing curcumin for oral squamous cell carcinoma treatment: From pre-formulation to cytotoxicity in tissue-engineering oral mucosa
- Author
-
Klaudia M. Slowik, Marcos Luciano Bruschi, Lidiane Vizioli de Castro Hoshino, Mauro Luciano Baesso, Helen E. Colley, Sabrina Barbosa de Souza Ferreira, and Craig Murdoch
- Subjects
Curcumin ,Swine ,Pharmaceutical Science ,02 engineering and technology ,Pharmacology ,030226 pharmacology & pharmacy ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Drug Delivery Systems ,medicine ,Mucoadhesion ,Animals ,Oral mucosa ,Cytotoxicity ,Isopropyl myristate ,Squamous Cell Carcinoma of Head and Neck ,Mouth Mucosa ,Permeation ,021001 nanoscience & nanotechnology ,Bioavailability ,medicine.anatomical_structure ,chemistry ,Head and Neck Neoplasms ,Poloxamer 407 ,Carcinoma, Squamous Cell ,Mouth Neoplasms ,0210 nano-technology ,medicine.drug - Abstract
Current oral squamous cell carcinoma chemotherapies demonstrate off-target toxicity, which could be reduced by local delivery. Curcumin acts via many cellular targets to give anti-cancer properties; however the bioavailability is hindered by its physicochemical characteristics. The incorporation of curcumin into emulgel systems could be a promising approach for its solubilization and delivery. The aim of this work was to develop emulgel systems containing curcumin for the treatment of oral cancer. The emulgels containing curcumin were prepared with poloxamer 407, acrylic acid derivatives, oil phase (sesame oil or isopropyl myristate). The more stable system was evaluated for mechanical and rheological properties, as well as, the in vitro drug release profile, permeation and cytotoxic potential to oral mucosa models. The flow-throw system evidenced that the formulations could keep 5 min over porcine oral mucosa. Emulgel showed pseudoplastic behavior and a gelation temperature of 33 °C, which ensure their higher consistency. In addition, 70% of the incorporated curcumin was released within 24 h in an in vitro drug release study and could permeate porcine oral mucosa. Monolayers cultures and tissue-engineered models showed the selectivity of the drug and systems for tumor cells. The physicochemical properties, subsequent release and permeation of curcumin to selectivity kill cancer cells could be improved by the incorporation into emulgel systems.
- Published
- 2020